Forian Inc. Common Stock (FORA) is a publicly traded Healthcare sector company. As of November 11, 2026, FORA trades at $2.17 with a market cap of $67.79M and a P/E ratio of -13.56. FORA moved +0.46% today. Year to date, FORA is +6.37%; over the trailing twelve months it is +16.67%. Its 52-week range spans $1.64 to $2.71. Rallies surfaces FORA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Probe Targets Forian Inc.'s $2.17-Per-Share Sale to CEO-Led Consortium: Halper Sadeh LLC is investigating Forian Inc.'s $2.17-per-share going-private sale to an investor group led by CEO Max Wygod for potential fiduciary breaches and shareholder harm. The firm warns the deal terms could limit superior bids and invites shareholders to explore rights and opt for contingent-fee legal representation.
| Metric | Value |
|---|---|
| Price | $2.17 |
| Market Cap | $67.79M |
| P/E Ratio | -13.56 |
| EPS | $-0.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.71 |
| 52-Week Low | $1.64 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $30.05M |
| Net Income | $-5.11M |
| Gross Margin | 47.19% |
FORA analyst coverage data. Average price target: $0.00.